NIH-funded research R01 grant

Understanding how Ras signaling affects facial and dental development

Official title: Mechanisms of hyperactive Ras signaling in craniofacial and dental diseases

Funded at Cedars-Sinai Medical Center · NIH-11073943 · Data updated 2026-11-12

This study is looking into how certain genetic changes can cause problems with facial and dental development in people with RASopathies, and it invites patients to help researchers learn more about these conditions by comparing their experiences and participating in experiments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startMarch 10, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$600,029
NIH project number1R01DE033576-01A1
Project IDNIH-11073943 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with RASopathies, particularly those experiencing craniofacial and dental malformations.

Less likely to help

Patients without RASopathies or those not exhibiting craniofacial or dental issues may not benefit from this research.

What this research studies

This research investigates the mechanisms behind craniofacial and dental malformations caused by mutations in the Ras/MAPK signaling pathway, which are linked to a group of syndromes known as RASopathies. By studying both human patients and mouse models, the research aims to uncover how these genetic mutations disrupt normal bone and dental formation. The approach includes advanced techniques such as transcriptomic and proteomic analyses, as well as the use of patient-derived stem cells to explore the cellular processes involved. Patients may contribute to the understanding of their conditions through comparative morphometrics and functional experiments.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnosis, treatment, and prevention strategies for craniofacial and dental defects associated with RASopathies.

How similar studies have gone: Previous research has shown promising results in understanding the effects of Ras signaling in related conditions, indicating that this approach has potential for success.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Klein, Ophir D — Cedars-Sinai Medical Center
  • Study coordinator: Klein, Ophir D

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.